EN
HI
Gujarat Terce Laboratories Chart
Gujarat Terce Laboratories Share Key Metrics
Volume
3209.00
Market Cap
25.79 CR
LTQ@LTP
1@35.25
ATP
34.7
Var Margin
29.79 %
Circuit Range
27.81-41.71
Delivery %
96.46 %
Value
1.11 L
ASM/GSM
No
Market Lot
1
Summary
Gujarat Terce Laboratories share price is ₹35.25 as of 31 May, 2026. The stock Gujarat Terce Laboratories intraday movement has stayed between ₹34.59 and ₹35.25, while on a 52-week basis,Gujarat Terce Laboratories price 52 week high is ₹60.01 & its 52 week low is ₹29.00.
In terms of trading activity, Gujarat Terce Laboratories has recorded a volume of 3209 shares, The Gujarat Terce Laboratories has a market cap of ₹7420300 CR. The stock’s Average Traded Price (ATP) stands at ₹34.70, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹35.25.
Gujarat Terce Laboratories operates within a circuit range of ₹27.81 – ₹41.71, with a Value of ₹1.11 L. The Delivery Percentage for the day is 96.46%. Additionally, Gujarat Terce Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Gujarat Terce Laboratories Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.96
Sector P/B
3.02
Sec. Div. Yield
0.55
Gujarat Terce Laboratories Resistance and Support
Pivot 34.97
Resistance
First Resistance
35.29
Second Resistance
35.82
Third Resistance
36.14
Support
First Support
34.44
Second Support
34.12
Third Support
33.59
Gujarat Terce Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results & A.G.M. |
| 2026-05-27 | Audited Results & A.G.M. |
| 2026-02-04 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-07-17 | Others |
| 2025-05-26 | Audited Results & Others |
| 2025-02-04 | Quarterly Results |
Gujarat Terce Laboratories News
Gujarat Terce Laboratories Ltd - 524314 - Board Meeting Outcome for Outcome Of Board Meeting Held On 29 May 2026
Gujarat Terce Labs announced Q4 FY26 revenue of ₹11.40 crores (down 8.15% YoY) and net profit of ₹0.10 crores (from loss of ₹3.39 crores YoY). The board also approved the re-appointment of Mr. Aalap Prajapati as Managing Director & CEO for a five-year term starting October 28, 2026, pending shareholder approval.
May 29 2026 22:39:14
Gujarat Terce Laboratories Ltd - 524314 - Announcement under Regulation 30 (LODR)-Change in Directorate
Gujarat Terce Laboratories' Board has approved the re-appointment of Mr. Aalap Prajapati as the Managing Director & CEO for a 5-year term, effective October 28, 2026, subject to shareholder approval. This ensures leadership continuity for the micro-cap company.
May 29 2026 22:31:45
Read More
Gujarat Terce Laboratories Management
| Name | Position |
|---|---|
| Viplav S Khamar | Non Executive Independent Director |
| SP Sharma | Non Executive Independent Director |
Gujarat Terce Laboratories Similar Stocks
Deccan Health Care Ltd.
12.96
0.18 (1.41%)
Tejnaksh Healthcare Ltd.
15.15
-0.24 (1.56%)
Chennai Meenakshi Multispeciality Hospital Ltd.
38.69
-0.66 (1.68%)
Gujarat Inject (Kerala) Ltd.
112.75
2.00 (1.81%)
Bacil Pharma Ltd.
49.05
-2.04 (3.99%)
Ishita Drugs & Industries Ltd.
81.90
1.56 (1.94%)
Emmessar Biotech & Nutrition Ltd.
25.92
-0.01 (0.04%)
Gujarat Terce Laboratories FAQs
The Buying Price of Gujarat Terce Laboratories share is 35.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gujarat Terce Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gujarat Terce Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gujarat Terce Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gujarat Terce Laboratories shares is 0. Useful to assess the stock's value relative to its book value.
To assess Gujarat Terce Laboratories’s valuation compare Sector P/E, P/B which are 69.96 & 3.02 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gujarat Terce Laboratories is 25.79 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gujarat Terce Laboratories share price is 60.01 & 29.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gujarat Terce Laboratories belongs to the Healthcare sector.
